The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2023 | The functional role of CD4- and CD8-expressing T-cells in AML
Hussein Abbas, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, explores the functional role of different T-cell phenotypes in the bone marrow and peripheral blood in acute myeloid leukemia (AML). He mentions that CD4-expressing cells, as well as CD8-expressing cells, play an important role in mediating response and resistance to treatment. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
